This compound is primarily utilized in biochemical research and pharmaceutical development as a reactive intermediate for conjugation reactions. It is often employed in the synthesis of modified biomolecules, particularly for labeling proteins, peptides, or antibodies. The succinimidyl ester group facilitates efficient coupling with primary amines, enabling the attachment of the chroman moiety to target molecules. This modification can impart antioxidant properties or serve as a fluorescent probe, depending on the application. Its tetrahydro-2H-pyran-2-yloxy group provides protection during synthesis, allowing selective deprotection in subsequent steps. The compound is particularly valuable in studies involving oxidative stress, cellular imaging, or drug delivery systems, where its chroman structure can enhance stability or biological activity.